AstraZeneca wins U.S. approval for two-in-one diabetes pill
October 30, 2014 at 03:13 AM EDT
LONDON, Oct 30 (Reuters) - A new two-in-one diabetes pill from AstraZeneca has been approved by U.S. regulators, the British drugmaker said on Thursday.
